FDA Inspection 1109935 — Eurofins BioPharma Product Testing Hamburg GmbH
The FDA completed an inspection of Eurofins BioPharma Product Testing Hamburg GmbH on September 18, 2019 in Hamburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hamburg (Germany)